Systematic identification of transcription factors associated with patient survival in cancers

<p>Abstract</p> <p>Background</p> <p>Aberrant activation or expression of transcription factors has been implicated in the tumorigenesis of various types of cancer. In spite of the prevalent application of microarray experiments for profiling gene expression in cancer s...

Full description

Bibliographic Details
Main Authors: Alves Pedro, Li Lei M, Cheng Chao, Gerstein Mark
Format: Article
Language:English
Published: BMC 2009-05-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/10/225
id doaj-3fa67e2f9c224c08b3e4776c2398bb00
record_format Article
spelling doaj-3fa67e2f9c224c08b3e4776c2398bb002020-11-24T22:30:37ZengBMCBMC Genomics1471-21642009-05-0110122510.1186/1471-2164-10-225Systematic identification of transcription factors associated with patient survival in cancersAlves PedroLi Lei MCheng ChaoGerstein Mark<p>Abstract</p> <p>Background</p> <p>Aberrant activation or expression of transcription factors has been implicated in the tumorigenesis of various types of cancer. In spite of the prevalent application of microarray experiments for profiling gene expression in cancer samples, they provide limited information regarding the activities of transcription factors. However, the association between transcription factors and cancers is largely dependent on the transcription regulatory activities rather than mRNA expression levels.</p> <p>Results</p> <p>In this paper, we propose a computational approach that integrates microarray expression data with the transcription factor binding site information to systematically identify transcription factors associated with patient survival given a specific cancer type. This approach was applied to two gene expression data sets for breast cancer and acute myeloid leukemia. We found that two transcription factor families, the steroid nuclear receptor family and the ATF/CREB family, are significantly correlated with the survival of patients with breast cancer; and that a transcription factor named T-cell acute lymphocytic leukemia 1 is significantly correlated with acute myeloid leukemia patient survival.</p> <p>Conclusion</p> <p>Our analysis identifies transcription factors associating with patient survival and provides insight into the regulatory mechanism underlying the breast cancer and leukemia. The transcription factors identified by our method are biologically meaningful and consistent with prior knowledge. As an insightful tool, this approach can also be applied to other microarray cancer data sets to help researchers better understand the intricate relationship between transcription factors and diseases.</p> http://www.biomedcentral.com/1471-2164/10/225
collection DOAJ
language English
format Article
sources DOAJ
author Alves Pedro
Li Lei M
Cheng Chao
Gerstein Mark
spellingShingle Alves Pedro
Li Lei M
Cheng Chao
Gerstein Mark
Systematic identification of transcription factors associated with patient survival in cancers
BMC Genomics
author_facet Alves Pedro
Li Lei M
Cheng Chao
Gerstein Mark
author_sort Alves Pedro
title Systematic identification of transcription factors associated with patient survival in cancers
title_short Systematic identification of transcription factors associated with patient survival in cancers
title_full Systematic identification of transcription factors associated with patient survival in cancers
title_fullStr Systematic identification of transcription factors associated with patient survival in cancers
title_full_unstemmed Systematic identification of transcription factors associated with patient survival in cancers
title_sort systematic identification of transcription factors associated with patient survival in cancers
publisher BMC
series BMC Genomics
issn 1471-2164
publishDate 2009-05-01
description <p>Abstract</p> <p>Background</p> <p>Aberrant activation or expression of transcription factors has been implicated in the tumorigenesis of various types of cancer. In spite of the prevalent application of microarray experiments for profiling gene expression in cancer samples, they provide limited information regarding the activities of transcription factors. However, the association between transcription factors and cancers is largely dependent on the transcription regulatory activities rather than mRNA expression levels.</p> <p>Results</p> <p>In this paper, we propose a computational approach that integrates microarray expression data with the transcription factor binding site information to systematically identify transcription factors associated with patient survival given a specific cancer type. This approach was applied to two gene expression data sets for breast cancer and acute myeloid leukemia. We found that two transcription factor families, the steroid nuclear receptor family and the ATF/CREB family, are significantly correlated with the survival of patients with breast cancer; and that a transcription factor named T-cell acute lymphocytic leukemia 1 is significantly correlated with acute myeloid leukemia patient survival.</p> <p>Conclusion</p> <p>Our analysis identifies transcription factors associating with patient survival and provides insight into the regulatory mechanism underlying the breast cancer and leukemia. The transcription factors identified by our method are biologically meaningful and consistent with prior knowledge. As an insightful tool, this approach can also be applied to other microarray cancer data sets to help researchers better understand the intricate relationship between transcription factors and diseases.</p>
url http://www.biomedcentral.com/1471-2164/10/225
work_keys_str_mv AT alvespedro systematicidentificationoftranscriptionfactorsassociatedwithpatientsurvivalincancers
AT lileim systematicidentificationoftranscriptionfactorsassociatedwithpatientsurvivalincancers
AT chengchao systematicidentificationoftranscriptionfactorsassociatedwithpatientsurvivalincancers
AT gersteinmark systematicidentificationoftranscriptionfactorsassociatedwithpatientsurvivalincancers
_version_ 1725740125157064704